Please login to the form below

Not currently logged in
Email:
Password:

Turing Pharma

This page shows the latest Turing Pharma news and features for those working in and with pharma, biotech and healthcare.

Pfizer gets record £84m fine for hiking price of epilepsy drug

Pfizer gets record £84m fine for hiking price of epilepsy drug

The case suggests that massive price hikes for off-patent drugs - particularly those with few alternatives - may not only be a phenomenon in the US, where Turing Pharma's 5, 000% ... increase for toxoplasmosis drug Daraprim (pyrimethamine) prompted a

Latest news

  • Allergan CEO takes issue with 'predatory' price increases Allergan CEO takes issue with 'predatory' price increases

    Allergan chief executive Brent Saunders has slammed aggressive price increases in the pharma sector, saying they break an "unwritten social contract". ... Meanwhile other companies - including Valeant, Turing Pharma and Horizon Pharma - have also been

  • Post-Shkreli KaloBios pledges transparent pricing Post-Shkreli KaloBios pledges transparent pricing

    That runs counter to comments made by Shkreli when he was CEO of Turing Pharma, arguing that the massive price hike for Daraprim (pyrimethamine), a drug used to treat the parasitic

  • FDA allows accelerated review for rivals to over-priced drugs FDA allows accelerated review for rivals to over-priced drugs

    Notable examples include Turing Pharma's decision to increase the price of Daraprim (pyrimethamine), a long-established drug to treat a parasitic infection affecting HIV patients, from $13.50 to $750 ... These and other pricing decisions have focused

  • Shkreli fallout claims Turing jobs and KaloBios' listing Shkreli fallout claims Turing jobs and KaloBios' listing

    Shkreli fallout claims Turing jobs and KaloBios' listing. Both firms continue to suffer with job cuts and de-listing from the Nasdaq. ... The repercussions of Martin Shkreli's arrest continue to be felt, with Turing Pharma announcing job cuts and

  • Update: Shkreli resigns as Turing CEO, ousted from KaloBios Update: Shkreli resigns as Turing CEO, ousted from KaloBios

    Shkreli will be replaced on an interim basis by Ron Tilles, Turing Pharma's chairman, at the privately held company, which has offices in New York and Zug in Switzerland. ... 50 per pill to $750 per pill, sparking accusations of applying 'hedge fund

More from news
Approximately 2 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    Turing Pharma disaster. ... Digital health is expected to be a major investment area for a wider variety of pharma companies.

  • Pharma deals in September 2015 Pharma deals in September 2015

    Ophthalmic, metabolic, dermatological, autoimmune and anti-infective based deals also featured. The loudest noise, however, was the ricochet created by Turing Pharma's newly acquired, 62 year old drug, daraprim, to ... In addition to Turing Pharma, Deal

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

Porterhouse Medical provides medical and scientific communication services to the pharmaceutical industry across the globe, with a focus on solutions...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics